{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Time to the first occurrence of relapse, progression, secondary cancer or death from any cause.","groups":[{"description":"Regimen C: Radiation therapy plus pazopanib","id":"OG000","title":"Regimen C"},{"description":"Regimen D: Radiation therapy alone","id":"OG001","title":"Regimen D"}],"populationDescription":"Data for the phase III portion of the study were never collected because the RT arm was closed earlier due to slow accrual.","reportingStatus":"POSTED","timeFrame":"From enrollment to up to 60 months","title":"Percentage of Radiotherapy Patients Failure Free at 5 Years Following Study Entry","type":"PRIMARY"}